Delivery Order SPE2DB22D1106-SPE2DB25FEME1
Award Date
5/6/25
Potential Completion Date
5/7/25
Potential Value
$7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,108.93 firm-fixed-price delivery order is for the medication Trelegy Ellipta, a combination treatment for chronic obstructive pulmonary disease. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,847.79, is for the delivery of Trelegy Ellipta 100-62.5-25 60s, a medication used for the treatment of chronic obstructive pulmonary disease (COPD). This is a firm-fixed-price delivery order contract with a period of performance through November 28, 2023. The contract does...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,127.45 firm fixed-price delivery order is for the drug Trelegy Ellipta, an inhalation medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of May 28, 2024. This award is part of a larger $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,609.96 firm fixed-price delivery order is for the medication Trelegy Ellipta, a treatment used for chronic obstructive pulmonary disease (COPD). The award has an ultimate completion date of April 3, 2023 and was made on March 31, 2023. The contract does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,896.68 firm fixed-price delivery order is for the supply of Trelegy Ellipta 100-62.5-25 60s, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of December 9, 2024 and was awarded on December 6, 2024. This award is part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,887.89 firm-fixed-price delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication. The contract has a completion date of June 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,320.69 delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a medication used for the treatment of chronic obstructive pulmonary disease (COPD). The contract has a firm fixed price and an ultimate completion date of July 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,165.19 firm fixed-price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s, a medication used to treat chronic obstructive pulmonary disease (COPD). The award has a performance period extending through May 7, 2025 and is not set aside for any particular business category....
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,460.94 firm-fixed-price delivery order is for the supply of Trelegy Ellipta 100-62.5-25 60S, a respiratory medication. The contract has an ultimate completion date of August 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $5,248.75 from the Defense Logistics Agency (DLA). The award is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has a completion date of May 1, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...